ORASIS Trademark

Trademark Overview

On Thursday, February 25, 2016, a trademark application was filed for ORASIS with the United States Patent and Trademark Office. The USPTO has given the ORASIS trademark a serial number of 86919307. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Thursday, May 5, 2022. This trademark is owned by Orasis Pharmaceuticals Ltd. The ORASIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of eye disorders and diseases
orasis

General Information

Serial Number86919307
Word MarkORASIS
Filing DateThursday, February 25, 2016
Status711 - CANCELLED - SECTION 7
Status DateThursday, May 5, 2022
Registration Number6061287
Registration DateTuesday, May 26, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 17, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of eye disorders and diseases
Translation of Words in MarkThe English translation of "ORASIS" in the mark is "VISION".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateThursday, May 5, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOrasis Pharmaceuticals Ltd
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHerzliya 4673306
IL
Party NameOrasis Pharmaceuticals Ltd
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHerzliya 4673306
IL
Party NameOrasis Pharmaceuticals Ltd
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHerzliyya, 4673327
IL

Trademark Events

Event DateEvent Description
Friday, May 6, 2022NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Thursday, May 5, 2022CANCELLED SECTION 7-TOTAL
Tuesday, August 31, 2021REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Wednesday, February 16, 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, February 4, 2022POST REGISTRATION ACTION MAILED - SEC. 7
Wednesday, February 2, 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, December 28, 2021POST REGISTRATION ACTION MAILED - SEC. 7
Tuesday, December 28, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 3, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 31, 2021TEAS SECTION 7 SURRENDER RECEIVED
Tuesday, May 26, 2020REGISTERED-PRINCIPAL REGISTER
Monday, April 20, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 20, 2020TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, April 20, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 20, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 20, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 20, 2020TTAB RELEASE CASE TO TRADEMARKS
Monday, April 20, 2020OPPOSITION TERMINATED NO. 999999
Monday, April 20, 2020OPPOSITION DISMISSED NO. 999999
Tuesday, November 13, 2018OPPOSITION INSTITUTED NO. 999999
Wednesday, August 15, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 27, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 14, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 11, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 11, 2018DATA MODIFICATION COMPLETED
Monday, June 11, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 1, 2018ASSIGNED TO LIE
Monday, May 28, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 17, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, January 17, 2018INQUIRY TO SUSPENSION E-MAILED
Wednesday, January 17, 2018SUSPENSION INQUIRY WRITTEN
Monday, July 17, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 17, 2017LETTER OF SUSPENSION E-MAILED
Monday, July 17, 2017SUSPENSION LETTER WRITTEN
Thursday, January 5, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 5, 2017LETTER OF SUSPENSION E-MAILED
Thursday, January 5, 2017SUSPENSION LETTER WRITTEN
Wednesday, December 14, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 14, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 14, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2016ASSIGNED TO LIE
Wednesday, November 23, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 1, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 1, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 15, 2016LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Wednesday, July 13, 2016LETTER OF PROTEST EVIDENCE FORWARDED
Friday, June 17, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 17, 2016NON-FINAL ACTION E-MAILED
Friday, June 17, 2016NON-FINAL ACTION WRITTEN
Thursday, June 9, 2016ASSIGNED TO EXAMINER
Tuesday, March 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 29, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

orasis diseases disorders treatment preparations pharmaceutical